Navigation Links
Medpace Opens Clinical Pharmacology Unit in Cincinnati, Ohio
Date:12/18/2007

CINCINNATI, Dec. 18 /PRNewswire/ -- Medpace, a leading global full-service contract research organization (CRO), is opening a 50 bed clinical pharmacology unit in Cincinnati, Ohio. The Medpace Clinical Pharmacology Unit (Medpace CPU) is a state-of-the-art Phase I, IIa facility, focusing on confined/controlled pharmacokinetic/pharmacodynamic studies utilizing human volunteers, with first-in-man capability.

The Medpace CPU is led by Jean Siebenaler, MD, who has extensive experience in clinical practice and CRO project management. The Medpace CPU will be managed by a team of highly trained, clinical research professionals, who are experts in the design, implementation, and analysis of Phase I and IIa studies. Jim Wei, MD, PhD, will be responsible for reviewing the early Phase studies of sponsors' products, recommending studies, and assisting with Phase I/Phase IIa study designs. Dr. Wei comes to Medpace from the FDA where he served as a Senior Reviewer in the Office of Clinical Pharmacology for almost 10 years where he was heavily involved in reviewing NDAs and INDs for the Divisions of Metabolism and Endocrinology Products.

Aligned with the Medpace approach of providing therapeutically focused clinical development services, the Medpace CPU will uniquely focus on studies in defined metabolic patient populations. The company's dedicated subject recruitment division, together with a strategic partnership with the renowned Metabolic and Atherosclerosis Research Center (MARC) led by Dr. Evan Stein, will facilitate efficient recruitment of populations which include: diabetics (Types I and II), patients with metabolic syndromes and cardiovascular diseases.

The secure, state-of-the-art, 24-hour, 7-day a week facility, features a thirteen bed intensive care/observation unit. The Medpace CPU is located across the street from the Medpace Reference Laboratories, a full service central lab which features therapeutically specialized testing. The site wil
'/>"/>

SOURCE Medpace
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
2. Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
3. New Risk Gene for Rheumatoid Arthritis and Lupus Opens Door to More Effective Treatments
4. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
5. PPD Opens Offices in Sydney, Australia; Copenhagen, Denmark; Lima, Peru; and Lisbon, Portugal
6. Pilot Study Opens the Door for Avastin Use in Curative Setting for Women With Breast Cancer
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
9. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
10. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
11. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... 2014 ... has announced the addition of the ... to their offering.      (Logo: ... of chromosomes using molecular biology to understand ... chromosomes. It plays a crucial role in ...
(Date:9/18/2014)... , Sept. 18, 2014  Low T ... committee meeting in Hyattsville, Maryland ... to assess the proper patient population for testosterone ... cardiovascular risk associated with TRT. Examining recent claims from ... found that "available epidemiological studies do not provide ...
(Date:9/18/2014)... CITY, Kan. , Sept. 18, 2014 /PRNewswire/ ... a pet therapeutics company focused on licensing, developing ... today announced the full exercise of the underwriters, ... stock in connection with the company,s previously announced ...  All of the shares are being offered by ...
Breaking Medicine Technology:Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 2Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 3Low T Center Endorses The Joint FDA Committee Meeting on Testosterone 2Aratana Therapeutics, Inc. Announces Full Exercise of Underwriters' Option to Purchase Additional Shares 2
(Date:9/18/2014)... 19, 2014 Today, Zane Benefits, the ... why to switch employees to individual health insurance. ... be more familiar with traditional, group health insurance, there ... employees happier. , The new article provides the ... health insurance rather than group health insurance, and why ...
(Date:9/18/2014)... (PRWEB) September 19, 2014 Reduce bags ... ingredients made just for these issues in a serum. ... Haloxyl and Eyeliss," says Kathy Heshelow, founder of Sublime ... circulation and boosting collagen, to improve the eye area." ... serum for wrinkles, dark circles and bags at ...
(Date:9/18/2014)... 19, 2014 When Mary Ann Thompson and Mathieu ... who live in Bali, Indonesia with their son, Isaac, said there ... two met at Mercy College in 2001 when Thompson was an ... was a graduate student at the time, was French and so ... and migrated to the United States when she was 7 years ...
(Date:9/18/2014)... 18, 2014 Defendants in more ... currently pending in Pennsylvania’s Philadelphia Court of Common ... on behalf of out-of-state plaintiffs dismissed, Bernstein Liebhard ... 11th, the defendants maintain that circumstances surrounding the ... lawsuits have no connection to Pennsylvania. The filings ...
(Date:9/18/2014)... Active Aging Week is a week-long observance ... members of society and promotes the benefits of leading ... a boutique retirement community located at 1200 Overlook Drive, ... of Cyber-Seniors - a humorous and heartwarming documentary. , ... this great film,” says Thomas Cloutier, Executive Director for ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Publishes New Information on Why Employees Are Happier with Individual Health Insurance 2Health News:The Secret to Improving Under-Eye Skin: 30% Off Sale and Report on Ingredients Ends Tonight on the Face Whisperer® Advanced Eye Gel 2Health News:For The First Time in Over a Decade Mercy College Alumni Marry at College 2Health News:Xarelto Lawsuit Defendants Seek to Have Pennsylvania Claims Filed by Out-of-State Plaintiffs Dismissed, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit Defendants Seek to Have Pennsylvania Claims Filed by Out-of-State Plaintiffs Dismissed, Bernstein Liebhard LLP Reports 3Health News:In Support of Active Aging Week, a Lake Oswego Retirement Community Will Get a Sneak Peek at an Inter-Generational Documentary – Cyber-Seniors 2
... By Jenifer Goodwin HealthDay Reporter , ... genetic variants implicated in ADHD (attention-deficit/hyperactivity disorder) overlap with ... in autism, a new study finds. The ... ADHD, autism and other neuropsychiatric disorders sometimes have symptoms ...
... teenagers prefer social media over the telephone, you may want ... involved in research studies. When 188 ninth-11th graders in ... be contacted about their participation in a Georgia Health Sciences ... contact via cell and/or land line with a recorded message ...
... WEDNESDAY, Aug. 10 (HealthDay News) -- The breast cancer drug ... especially those with a history of heart disease and/or diabetes, ... of 45 women, ages 70 to 92, who were treated ... percent) of them developed heart problems caused by the drug. ...
... Aug. 10 (HealthDay News) -- Eating red meat -- especially ... of type 2 diabetes, a new study warns. It ... by replacing red meat with healthier proteins, such as nuts, ... Public Health researchers looked at 20 years of data from ...
... have had so far with the much-heralded field of nanotechnology ... of Chemical & Engineering News (C&EN), the American ... science of ultra-small particles so tiny that 50,000 could ... come when sunbathers, golfers, bikers and others slather on sunscreen ...
... DURHAM, N.H. A University of New Hampshire researcher ... pro-eugenic beliefs manipulated his research findings so he could ... mentally and morally "unfit" people. Benjamin Harris, professor ... has found that Yale psychologist Arnold Gesell manipulated the ...
Cached Medicine News:Health News:ADHD, Autism May Sometimes Share Gene Mutations 2Health News:ADHD, Autism May Sometimes Share Gene Mutations 3Health News:Telephone trumps social media when communicating with teens about research 2Health News:Breast Cancer Drug Raises Risk of Heart Problems in Older Women: Study 2Health News:Daily Hot Dog May Feed Diabetes Risk: Study 2Health News:UNH researcher discovers research manipulated to support pro-eugenic beliefs 2Health News:UNH researcher discovers research manipulated to support pro-eugenic beliefs 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: